Furthermore, TAMs also promoted tumor progression under hypoxia by interacting with corresponding receptors, such as EGFR- and FGFR2-promoting tumor cell proliferation, CD44-promoting tumor invasiveness, and VEGF-inducing angiogenesis to increase invasion ability of tumor cells. This evidence concerns the gene CD44 and neoplasm.